Clinical Trials Browser

OTHER × Adjuvants, Immunologic × 30 days × Clear all

NCT06130826 2026-06-03

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

Phase 1 Suspended

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms